Serial #97331599
LIVE

Serial Number

97331599

Owner

The Board of Regents of The University of Texas System

Attorney

Robin Lightner Maisashvili

First Use Date

Nov 14, 2023

Filing Date

Mar 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

Serial #97331599 Trademark

Serial Number: 97331599 • Registration: 8023907

Serial #97331599 is a trademark filed by The Board of Regents of The University of Texas System on March 25, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

The Board of Regents of The University of Texas System (255 trademarks)

201 West 7th Street
Austin, TX 78701

Entity Type: 14

Trademark Details

Filing Date

March 25, 2022

Registration Date

November 11, 2025

First Use Anywhere

November 14, 2023

First Use in Commerce

November 14, 2023

Published for Opposition

January 30, 2024

Goods & Services

Educational services, namely, conducting programs, seminars and lectures in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer and diseases

Charitable fundraising services

Promoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease

Medical services; Medical services relating to cancer; providing medical information; providing health information in the field of immunobiology, immunotherapy, oncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases; providing medical information, consultancy and advisory services; providing information on cancer treatment; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment

Medical research services; medical research, development, technical design, testing, and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; consulting services in the fields of immunobiology, immunotherapy, antibodies, and oncology research, development, testing, analysis and data; medical research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology; biological research; laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, immunobiology, immunotherapy, pharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; pharmaceutical research services; pharmaceutical research services relating to cancer

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 21, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 21, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 2, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 2, 2025 AITU
USE AMENDMENT FILED
May 5, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
May 5, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 27, 2025 EXRA
SOU EXTENSION 2 GRANTED
Mar 27, 2025 EX2G
SOU EXTENSION 2 FILED
Mar 26, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 26, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 25, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 25, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 25, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 25, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 26, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 28, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2023 CRFA
ASSIGNED TO LIE
Dec 4, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 29, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 3, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 3, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 29, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 25, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 1, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2022 NWOS
NEW APPLICATION ENTERED
Mar 29, 2022 NWAP